Related Experiment Video
Updated: Aug 8, 2026

Isolation of Primary Myofibroblasts from Mouse and Human Colon Tissue
Published on: October 13, 2013
Decreased stability of transforming growth factor beta type II receptor mRNA in RER+ human colon carcinoma cells
W Jiang1, M P Tillekeratne, M G Brattain
1Department of Biochemistry and Molecular Biology, Medical College of Ohio, Toledo 43699, USA.
Abstract:
Transforming growth factor beta (TGF-beta) is a potent inhibitor of cell growth and tumor progression. Previous work has shown that loss of functional TGF-beta type II receptor (RII) due to a frameshift mutation in the 5' half of the RII gene leads to TGF-beta resistance in a highly progressed, RER+ human colon carcinoma cell line designated HCT116. Expression of this mutated RII gene was highly repressed in RER+ cell lines such as HCT116 and RKO, as analyzed by RNase protection assays. Nuclear run-on and RII promoter-reporter (CAT) assays showed that the transcriptional levels of the RII gene in these RER+ cells were not reduced, compared to RII-expressing cells. However, the half-lives of the RII mRNA, as analyzed by RNase protection assays following actinomycin D treatment, were significantly decreased. This suggested that the decreased expression of the RII gene mutant was due to decreased mRNA stability. Furthermore, RII mRNA from HCT116 transfected with wild-type RII had a longer half-life than the endogenous mutated RII mRNA. A dominant negative RII mutant, which encodes a similarly truncated RII protein as HCT116 but lacks the extensive 3' untranslated region of RII mRNA, gave the same half-life as endogenous wild-type RII mRNA. We conclude that the frameshift mutation which results in a premature stop codon in the 5' half of the mRNA transcript accounts for the reduced RII mRNA levels in RER+ cells.
Insights
Loss of functional transforming growth factor beta type II receptor (RII) in colon cancer cells is due to decreased mRNA stability, not reduced transcription. A frameshift mutation causes premature stop codons, leading to reduced RII mRNA levels.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Transforming growth factor beta (TGF-beta) inhibits cell growth and tumor progression.
- Loss of functional TGF-beta type II receptor (RII) confers TGF-beta resistance.
- A frameshift mutation in the RII gene is linked to TGF-beta resistance in HCT116 colon cancer cells.
Purpose of the Study:
- To investigate the mechanism underlying the reduced expression of the mutated TGF-beta type II receptor (RII) in RER+ colon carcinoma cells.
- To determine if reduced RII expression is due to transcriptional repression or decreased mRNA stability.
Main Methods:
- RNase protection assays to analyze RII gene expression and mRNA half-life.
- Nuclear run-on and RII promoter-reporter (CAT) assays to assess transcriptional levels.
- Transfection experiments with wild-type and mutant RII constructs.
Main Results:
- RII gene expression was repressed in RER+ cell lines (HCT116, RKO).
- Transcriptional levels of RII were not reduced, but mRNA half-lives were significantly decreased in RER+ cells.
- Mutated RII mRNA exhibited shorter half-lives compared to wild-type RII mRNA.
Conclusions:
- Reduced RII mRNA levels in RER+ colon carcinoma cells are primarily due to decreased mRNA stability.
- A frameshift mutation causing a premature stop codon in the RII mRNA transcript is responsible for the reduced mRNA stability and expression.
- These findings elucidate a mechanism for TGF-beta resistance in colon cancer.
Related Concept Videos
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
TGF - β Signaling Pathway
Inflammatory Bowel Disease II: Ulcerative Colitis

